AMCP is partnering with industry leaders to host two AMCP Corporate Training Programs at AMCP Nexus 2020
- Health Care Actuaries: What are they and how do they influence payer decision making?
- Pre-Approval Information Exchange (PIE): Implementing pre-approval communication strategies
Health Care Actuaries: What are they and how do they influence payer decision making?
An AMCP and Optum Advisory Services Training Program.
Join leading managed care and health plan experts for an invaluable and interactive training program that introduces the role of a health plan actuary and illustrates the actuarial influences on payer decision making.
Pharmacy risk is big, changing, and uncertain, creating both financial risk and opportunities across the pharmacy ecosystem. Life science companies continue to innovate novel drug therapies especially within the specialty drug space and payers rely on actuaries to understand and incorporate the impacts of these therapies into the price of the insurance product. With this level of unprecedented change, stakeholders must navigate the complex operational, regulatory, and fiscal pharmacy environment.
This invaluable and interactive AMCP Corporate Training program will introduce the role of a health plan actuary, familiarize the audience with how a health plan actuary models and prepares for market disruptions, and then offers a deep dive into Medicare market dynamics through the lens of the health plan actuary. Learn more.
Tuesday, Oct. 20 | 11am-5:30pm
$1,995 (inclusive of meeting registration)
Cancellation Fee: $400
Registration cap: 60
Pre-Approval Information Exchange (PIE): Implementing pre-approval communication strategies
An AMCP Corporate Training program in collaboration with Xcenda
Is your company taking full advantage of Pre-Approval Information Exchange to support your next product launch? Are you ready to take the next step in enhancing dialog with payers about your products and devices under development?
This AMCP Corporate Training will provide attendees key insights and information on how to leverage PIE within FDA’s 2018 guidance. Payer representatives will provide their views on how this new business model is benefiting all stakeholders, including manufacturers in getting patients access to new medications.
Tuesday, Oct. 20 | 8am-noon
Price: $895 (add-on, not inclusive of a meeting registration)
Cancellation Fee: $200
Duration (4 hours including breakfast; includes pre-course materials)